Resultats de la cerca - Jeremy M. Shefner

Refinar resultats
  1. 1
    Monkey median nerve repaired by nerve graft or collagen nerve guide tube

    Monkey median nerve repaired by nerve graft or collagen nerve guide tube per SJ Archibald, Jeremy M. Shefner, Christian Krarup, RD Madison

    Publicat 1995
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    ALS longitudinal studies with frequent data collection at home: study design and baseline data

    ALS longitudinal studies with frequent data collection at home: study design and baseline data per Seward B. Rutkove, Kristin Qi, Kerisa Shelton, Julie Liss, Visar Berisha, Jeremy M. Shefner

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Lead Exposure and Amyotrophic Lateral Sclerosis

    Lead Exposure and Amyotrophic Lateral Sclerosis per Freya Kamel, David M. Umbach, Theodore L. Munsat, Jeremy M. Shefner, Howard Hu, Dale P. Sandler

    Publicat 2002
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Quantitative strength testing in ALS clinical trials

    Quantitative strength testing in ALS clinical trials per Jeremy M. Shefner, Dawei Liu, Melanie Leitner, David Schoenfeld, Donald R. Johns, Toby A. Ferguson, Merit Cudkowicz

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Early detection and tracking of bulbar changes in ALS via frequent and remote speech analysis

    Early detection and tracking of bulbar changes in ALS via frequent and remote speech analysis per Gabriela Stegmann, Shira Hahn, Julie Liss, Jeremy M. Shefner, Seward B. Rutkove, Kerisa Shelton, Cayla Jessica Duncan, Visar Berisha

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Quantifying disease progression in amyotrophic lateral sclerosis

    Quantifying disease progression in amyotrophic lateral sclerosis per Neil G. Simon, Martin R. Turner, Steve Vucic, Ammar Al‐Chalabi, Jeremy M. Shefner, Catherine Lomen‐Hoerth, Matthew C. Kiernan

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis

    Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis per Jinsy Andrews, Lisa Meng, Sarah Kulke, Stacy A. Rudnicki, Andrew A. Wolff, Michael Bozik, Fady I. Malik, Jeremy M. Shefner

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Improved ALS clinical trials through frequent at‐home self‐assessment: a proof of concept study

    Improved ALS clinical trials through frequent at‐home self‐assessment: a proof of concept study per Seward B. Rutkove, Pushpa Narayanaswami, Visar Berisha, Julie Liss, Shira Hahn, Kerisa Shelton, Kristin Qi, Sarbesh Pandeya, Jeremy M. Shefner

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Reducing sample size requirements for future ALS clinical trials with a dedicated electrical impedance myography system

    Reducing sample size requirements for future ALS clinical trials with a dedicated electrical impedance myography system per Jeremy M. Shefner, Seward B. Rutkove, James B. Caress, Michael Benatar, William S. David, Michael S. Cartwright, Eric A. Macklin, Jose L. Bohorquez

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Long‐term edaravone efficacy in amyotrophic lateral sclerosis: Post‐hoc analyses of Study 19 (MCI186‐19)

    Long‐term edaravone efficacy in amyotrophic lateral sclerosis: Post‐hoc analyses of Study 19 (MCI186‐19) per Jeremy M. Shefner, Terry Heiman‐Patterson, Erik P. Pioro, Martina Wiedau‐Pazos, X. Shawn Liu, Jeffrey Zhang, Wendy Agnese, Stephen Apple

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Biomarker Qualification for Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: Theory and Practice

    Biomarker Qualification for Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: Theory and Practice per Michael Benatar, Lyle W. Ostrow, Joseph W. Lewcock, Frank Bennett, Jeremy M. Shefner, Robert Bowser, Paul Larkin, Lucie Bruijn, Joanne Wuu

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  12. 12
    Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials

    Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials per Seward B. Rutkove, Hui Zhang, David Schoenfeld, Elizabeth M. Raynor, Jeremy M. Shefner, Merit Cudkowicz, Anne B. Chin, R. Aaron, C. A. Shiffman

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self‐report scale (Center for Neurologic Study Bulbar Function Scale)

    Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self‐report scale (Center for Neurologic Study Bulbar Function Scale) per Richard Smith, Eric A. Macklin, Kathleen Myers, Gary L. Pattee, Kimberly Goslin, Gregg Meekins, J. R. Green, Jeremy M. Shefner, Erik P. Pioro

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Repeatability of Commonly Used Speech and Language Features for Clinical Applications

    Repeatability of Commonly Used Speech and Language Features for Clinical Applications per Gabriela Stegmann, Shira Hahn, Julie Liss, Jeremy M. Shefner, Seward B. Rutkove, Kan Kawabata, Samarth Bhandari, Kerisa Shelton, Cayla Jessica Duncan, Visar Berisha

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

    Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial per Swati Aggarwal, Lorne Zinman, Elizabeth Simpson, Jane McKinley, Katherine E. Jackson, Hanika Pinto, Petra Kaufman, Robin Conwit, David Schoenfeld, Jeremy M. Shefner, Merit Cudkowicz

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Respiratory measures in amyotrophic lateral sclerosis

    Respiratory measures in amyotrophic lateral sclerosis per Noah Lechtzin, Merit Cudkowicz, Mamede de Carvalho, Angela Genge, Orla Hardiman, Hiroshi Mitsumoto, Jesús S. Mora, Jeremy M. Shefner, Leonard H. van den Berg, Jinsy Andrews

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Skeletal muscle in amyotrophic lateral sclerosis

    Skeletal muscle in amyotrophic lateral sclerosis per Jeremy M. Shefner, Antonio Musarò, Shyuan T. Ngo, Christian Lunetta, Frederik J. Steyn, Richard Robitaille, Mamede de Carvalho, Seward B. Rutkove, Albert C. Ludolph, Luc Dupuis

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  18. 18
    A phase III trial of <i>tirasemtiv</i> as a potential treatment for amyotrophic lateral sclerosis

    A phase III trial of <i>tirasemtiv</i> as a potential treatment for amyotrophic lateral sclerosis per Jeremy M. Shefner, Merit Cudkowicz, Orla Hardiman, Bettina M. Cockroft, Jacqueline H. Lee, Fady I. Malik, Lisa Meng, Stacy A. Rudnicki, Andrew A. Wolff, Jinsy Andrews

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Multipoint incremental motor unit number estimation as an outcome measure in ALS

    Multipoint incremental motor unit number estimation as an outcome measure in ALS per Jeremy M. Shefner, Mary Lou Watson, Laura Simionescu, James B. Caress, Ted M. Burns, Nicholas J. Maragakis, Michael Benatar, William S. David, Khema R. Sharma, Seward B. Rutkove

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking

    Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking per Shinji Hadano, Susanna C. Benn, Shigeru Kakuta, Asako Otomo, Katsuko Sudo, Ryota Kunita, Kyoko Suzuki-Utsunomiya, Hikaru Mizumura, Jeremy M. Shefner, Gregory A. Cox, Yoichiro Iwakura, Robert H. Brown, Joh‐E Ikeda

    Publicat 2005
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: